APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dermatology OTC Medications

Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.

Selected research

Industry Growth & Trends

Global Dermatology OTC Medications Industry Growth and Trends Forecast to 2032

26 December 2025114 pages

Choose your research edition.

Industry ResearchDermatology OTC Medications Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Dermatology OTC Medications Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Dermatology OTC Medications Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dermatology OTC Medications Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Dermatology OTC Medications Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.

Market competition is intense. Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 25.08% market share in 2019.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Dermatology OTC Medications market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Dermatology OTC Medications market size, estimates, and forecasts are presented in terms of sales volume (M Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dermatology OTC Medications market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dermatology OTC Medications.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Dermatology OTC Medications market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Dermatology OTC Medications Market by Company

Bayer

GSK

Teva

Johnson & Johnson

Novartis

Mylan

Sun Pharmaceutical

Aurobindo

Galderma

CR SANJIU

Dr. Reddy's

Lupin

Bausch Health

Cipla

Qilu Pharmaceutical

Almirall

Lingrui

Dermatology OTC Medications Segment by Type

External Use

Oral

Dermatology OTC Medications Segment by Application

Hospital

Drug Store

Other

Dermatology OTC Medications Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatology OTC Medications market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dermatology OTC Medications and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dermatology OTC Medications.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Dermatology OTC Medications manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Dermatology OTC Medications in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of External Use Table 2. Major Company of Oral Table 3. Global Dermatology OTC Medications Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Dermatology OTC Medications Sales by Type (2021-2026) & (M Units) Table 5. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2021-2026) Table 6. Global Dermatology OTC Medications Sales by Type (2021-2026) & (US$ Million) Table 7. Global Dermatology OTC Medications Sales Market Share in Value by Type (2021-2026) Table 8. Global Dermatology OTC Medications Price by Type (2021-2026) & (USD/Unit) Table 9. Global Dermatology OTC Medications Sales by Type (2027-2032) & (M Units) Table 10. Global Dermatology OTC Medications Sales Market Share in Volume by Type (2027-2032) Table 11. Global Dermatology OTC Medications Sales by Type (2027-2032) & (US$ Million) Table 12. Global Dermatology OTC Medications Sales Market Share in Value by Type (2027-2032) Table 13. Global Dermatology OTC Medications Price by Type (2027-2032) & (USD/Unit) Table 14. North America Dermatology OTC Medications Sales by Type (2021-2026) & (M Units) Table 15. North America Dermatology OTC Medications Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Dermatology OTC Medications Sales by Type (2021-2026) & (M Units) Table 17. Europe Dermatology OTC Medications Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Dermatology OTC Medications Sales by Type (2021-2026) & (M Units) Table 19. Asia-Pacific Dermatology OTC Medications Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Dermatology OTC Medications Sales by Type (2021-2026) & (M Units) Table 21. Latin America Dermatology OTC Medications Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Dermatology OTC Medications Sales by Type (2021-2026) & (M Units) Table 23. Middle East and Africa Dermatology OTC Medications Sales by Type (2021-2026) & (US$ Million) Table 24. Dermatology OTC Medications Industry Trends Table 25. Dermatology OTC Medications Industry Drivers Table 26. Dermatology OTC Medications Industry Opportunities and Challenges Table 27. Dermatology OTC Medications Industry Restraints Table 28. Global Dermatology OTC Medications Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Dermatology OTC Medications Revenue Market Share by Company (2021-2026) Table 30. Global Dermatology OTC Medications Sales by Company (2021-2026) & (M Units) Table 31. Global Dermatology OTC Medications Sales Share by Company (2021-2026) Table 32. Global Dermatology OTC Medications Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Dermatology OTC Medications Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Dermatology OTC Medications Major Company Production Sites and Headquarters Table 35. Global Dermatology OTC Medications Company, Product Type & Application Table 36. Global Dermatology OTC Medications Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Dermatology OTC Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Dermatology OTC Medications Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Dermatology OTC Medications Sales by Region (2021-2026) & (M Units) Table 41. Global Dermatology OTC Medications Sales Market Share in Volume by Region (2021-2026) Table 42. Global Dermatology OTC Medications Sales by Region (2021-2026) & (US$ Million) Table 43. Global Dermatology OTC Medications Sales Market Share in Value by Region (2021-2026) Table 44. Global Dermatology OTC Medications Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Dermatology OTC Medications Sales by Region (2027-2032) & (M Units) Table 46. Global Dermatology OTC Medications Sales Market Share in Volume by Region (2027-2032) Table 47. Global Dermatology OTC Medications Sales by Region (2027-2032) & (US$ Million) Table 48. Global Dermatology OTC Medications Sales Market Share in Value by Region (2027-2032) Table 49. Global Dermatology OTC Medications Sales (M Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Dermatology OTC Medications Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Dermatology OTC Medications Sales by Application (2021-2026) & (M Units) Table 52. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2021-2026) Table 53. Global Dermatology OTC Medications Sales by Application (2021-2026) & (US$ Million) Table 54. Global Dermatology OTC Medications Sales Market Share in Value by Application (2021-2026) Table 55. Global Dermatology OTC Medications Price by Application (2021-2026) & (USD/Unit) Table 56. Global Dermatology OTC Medications Sales by Application (2027-2032) & (M Units) Table 57. Global Dermatology OTC Medications Sales Market Share in Volume by Application (2027-2032) Table 58. Global Dermatology OTC Medications Sales by Application (2027-2032) & (US$ Million) Table 59. Global Dermatology OTC Medications Sales Market Share in Value by Application (2027-2032) Table 60. Global Dermatology OTC Medications Price by Application (2027-2032) & (USD/Unit) Table 61. North America Dermatology OTC Medications Sales by Application (2021-2026) & (M Units) Table 62. North America Dermatology OTC Medications Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Dermatology OTC Medications Sales by Application (2021-2026) & (M Units) Table 64. Europe Dermatology OTC Medications Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Dermatology OTC Medications Sales by Application (2021-2026) & (M Units) Table 66. Asia-Pacific Dermatology OTC Medications Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Dermatology OTC Medications Sales by Application (2021-2026) & (M Units) Table 68. Latin America Dermatology OTC Medications Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Dermatology OTC Medications Sales by Application (2021-2026) & (M Units) Table 70. Middle East and Africa Dermatology OTC Medications Sales by Application (2021-2026) & (US$ Million) Table 71. Bayer Company Information Table 72. Bayer Business Overview Table 73. Bayer Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Bayer Dermatology OTC Medications Product Portfolio Table 75. Bayer Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. GSK Dermatology OTC Medications Product Portfolio Table 80. GSK Recent Development Table 81. Teva Company Information Table 82. Teva Business Overview Table 83. Teva Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. Teva Dermatology OTC Medications Product Portfolio Table 85. Teva Recent Development Table 86. Johnson & Johnson Company Information Table 87. Johnson & Johnson Business Overview Table 88. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. Johnson & Johnson Dermatology OTC Medications Product Portfolio Table 90. Johnson & Johnson Recent Development Table 91. Novartis Company Information Table 92. Novartis Business Overview Table 93. Novartis Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Novartis Dermatology OTC Medications Product Portfolio Table 95. Novartis Recent Development Table 96. Mylan Company Information Table 97. Mylan Business Overview Table 98. Mylan Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Mylan Dermatology OTC Medications Product Portfolio Table 100. Mylan Recent Development Table 101. Sun Pharmaceutical Company Information Table 102. Sun Pharmaceutical Business Overview Table 103. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Sun Pharmaceutical Dermatology OTC Medications Product Portfolio Table 105. Sun Pharmaceutical Recent Development Table 106. Aurobindo Company Information Table 107. Aurobindo Business Overview Table 108. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Aurobindo Dermatology OTC Medications Product Portfolio Table 110. Aurobindo Recent Development Table 111. Galderma Company Information Table 112. Galderma Business Overview Table 113. Galderma Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Galderma Dermatology OTC Medications Product Portfolio Table 115. Galderma Recent Development Table 116. CR SANJIU Company Information Table 117. CR SANJIU Business Overview Table 118. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. CR SANJIU Dermatology OTC Medications Product Portfolio Table 120. CR SANJIU Recent Development Table 121. Dr. Reddy's Company Information Table 122. Dr. Reddy's Business Overview Table 123. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Dr. Reddy's Dermatology OTC Medications Product Portfolio Table 125. Dr. Reddy's Recent Development Table 126. Lupin Company Information Table 127. Lupin Business Overview Table 128. Lupin Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Lupin Dermatology OTC Medications Product Portfolio Table 130. Lupin Recent Development Table 131. Bausch Health Company Information Table 132. Bausch Health Business Overview Table 133. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. Bausch Health Dermatology OTC Medications Product Portfolio Table 135. Bausch Health Recent Development Table 136. Cipla Company Information Table 137. Cipla Business Overview Table 138. Cipla Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 139. Cipla Dermatology OTC Medications Product Portfolio Table 140. Cipla Recent Development Table 141. Qilu Pharmaceutical Company Information Table 142. Qilu Pharmaceutical Business Overview Table 143. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 144. Qilu Pharmaceutical Dermatology OTC Medications Product Portfolio Table 145. Qilu Pharmaceutical Recent Development Table 146. Almirall Company Information Table 147. Almirall Business Overview Table 148. Almirall Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 149. Almirall Dermatology OTC Medications Product Portfolio Table 150. Almirall Recent Development Table 151. Lingrui Company Information Table 152. Lingrui Business Overview Table 153. Lingrui Dermatology OTC Medications Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 154. Lingrui Dermatology OTC Medications Product Portfolio Table 155. Lingrui Recent Development Table 156. North America Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 157. North America Dermatology OTC Medications Sales by Country (2021-2026) & (M Units) Table 158. North America Dermatology OTC Medications Sales Market Share by Country (2021-2026) Table 159. North America Dermatology OTC Medications Sales Forecast by Country (2027-2032) & (M Units) Table 160. North America Dermatology OTC Medications Sales Market Share Forecast by Country (2027-2032) Table 161. North America Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Dermatology OTC Medications Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Dermatology OTC Medications Market Share by Country (2021-2026) Table 164. North America Dermatology OTC Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Dermatology OTC Medications Market Share Forecast by Country (2027-2032) Table 166. Europe Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 167. Europe Dermatology OTC Medications Sales by Country (2021-2026) & (M Units) Table 168. Europe Dermatology OTC Medications Sales Market Share by Country (2021-2026) Table 169. Europe Dermatology OTC Medications Sales Forecast by Country (2027-2032) & (M Units) Table 170. Europe Dermatology OTC Medications Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Dermatology OTC Medications Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Dermatology OTC Medications Market Share by Country (2021-2026) Table 174. Europe Dermatology OTC Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Dermatology OTC Medications Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Dermatology OTC Medications Sales by Country (2021-2026) & (M Units) Table 178. Asia-Pacific Dermatology OTC Medications Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Dermatology OTC Medications Sales Forecast by Country (2027-2032) & (M Units) Table 180. Asia-Pacific Dermatology OTC Medications Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Dermatology OTC Medications Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Dermatology OTC Medications Market Share by Country (2021-2026) Table 184. Asia-Pacific Dermatology OTC Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Dermatology OTC Medications Market Share Forecast by Country (2027-2032) Table 186. Latin America Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 187. Latin America Dermatology OTC Medications Sales by Country (2021-2026) & (M Units) Table 188. Latin America Dermatology OTC Medications Sales Market Share by Country (2021-2026) Table 189. Latin America Dermatology OTC Medications Sales Forecast by Country (2027-2032) & (M Units) Table 190. Latin America Dermatology OTC Medications Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Dermatology OTC Medications Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Dermatology OTC Medications Market Share by Country (2021-2026) Table 194. Latin America Dermatology OTC Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Dermatology OTC Medications Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country (M Units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Dermatology OTC Medications Sales by Country (2021-2026) & (M Units) Table 198. Middle East and Africa Dermatology OTC Medications Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Dermatology OTC Medications Sales Forecast by Country (2027-2032) & (M Units) Table 200. Middle East and Africa Dermatology OTC Medications Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Dermatology OTC Medications Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Dermatology OTC Medications Market Share by Country (2021-2026) Table 204. Middle East and Africa Dermatology OTC Medications Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Dermatology OTC Medications Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Dermatology OTC Medications Distributors List Table 209. Dermatology OTC Medications Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Dermatology OTC Medications Image Figure 2. Global Dermatology OTC Medications Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dermatology OTC Medications Market Size (2021-2032) & (US$ Million) Figure 4. Global Dermatology OTC Medications Sales (2021-2032) & (M Units) Figure 5. External Use Image Figure 6. Global External Use Sales YoY Growth (2021-2032) & (M Units) Figure 7. Oral Image Figure 8. Global Oral Sales YoY Growth (2021-2032) & (M Units) Figure 9. Global Dermatology OTC Medications Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Dermatology OTC Medications Market Share by Type 2025 VS 2032 Figure 11. North America Dermatology OTC Medications Sales Market Share in Volume by Type in 2025 Figure 12. North America Dermatology OTC Medications Sales Market Share in Value by Type in 2025 Figure 13. Europe Dermatology OTC Medications Sales Market Share in Volume by Type in 2025 Figure 14. Europe Dermatology OTC Medications Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Dermatology OTC Medications Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Type in 2025 Figure 17. Latin America Dermatology OTC Medications Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Dermatology OTC Medications Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Dermatology OTC Medications Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Dermatology OTC Medications Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (M Units) Figure 25. Drug Store Image Figure 26. Global Drug Store Sales YoY Growth (2021-2032) & (M Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (M Units) Figure 29. Global Dermatology OTC Medications Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Dermatology OTC Medications Market Share by Application 2025 VS 2032 Figure 31. North America Dermatology OTC Medications Sales Market Share in Volume by Application in 2025 Figure 32. North America Dermatology OTC Medications Sales Market Share in Value by Application in 2025 Figure 33. Europe Dermatology OTC Medications Sales Market Share in Volume by Application in 2025 Figure 34. Europe Dermatology OTC Medications Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Dermatology OTC Medications Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Dermatology OTC Medications Sales Market Share in Value by Application in 2025 Figure 37. Latin America Dermatology OTC Medications Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Dermatology OTC Medications Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Dermatology OTC Medications Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Dermatology OTC Medications Sales Market Share in Value by Application in 2025 Figure 41. North America Dermatology OTC Medications Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 42. North America Dermatology OTC Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Dermatology OTC Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Dermatology OTC Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Dermatology OTC Medications Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 46. Europe Dermatology OTC Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Dermatology OTC Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Dermatology OTC Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Dermatology OTC Medications Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 50. Asia-Pacific Dermatology OTC Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Dermatology OTC Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Dermatology OTC Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Dermatology OTC Medications Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 54. Latin America Dermatology OTC Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Dermatology OTC Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Dermatology OTC Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Dermatology OTC Medications Sales by Country: 2021 VS 2025 VS 2032 (M Units) Figure 58. Middle East and Africa Dermatology OTC Medications Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Dermatology OTC Medications Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Dermatology OTC Medications Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Dermatology OTC Medications Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Dermatology OTC Medications Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • External Use
  • Oral
Applications
  • Hospital
  • Drug Store
  • Other
Companies covered
  • Bayer
  • GSK
  • Teva
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Sun Pharmaceutical
  • Aurobindo
  • Galderma
  • CR SANJIU
  • Dr. Reddy's
  • Lupin
  • Bausch Health
  • Cipla
  • Qilu Pharmaceutical
  • Almirall
  • Lingrui

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dermatology OTC Medications Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Dermatology OTC Medications Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Dermatology OTC Medications Market by Type
  6. 1.3.1 External Use
  7. 1.3.2 Oral
  8. 1.4 Global Dermatology OTC Medications Market Size by Type
  9. 1.4.1 Global Dermatology OTC Medications Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Dermatology OTC Medications Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Dermatology OTC Medications Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Dermatology OTC Medications Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Dermatology OTC Medications Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Dermatology OTC Medications Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Dermatology OTC Medications Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Dermatology OTC Medications Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Dermatology OTC Medications Industry Trends
  2. 2.2 Dermatology OTC Medications Industry Drivers
  3. 2.3 Dermatology OTC Medications Industry Opportunities and Challenges
  4. 2.4 Dermatology OTC Medications Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Dermatology OTC Medications Revenue (2021-2026)
  2. 3.2 Global Top Players by Dermatology OTC Medications Sales (2021-2026)
  3. 3.3 Global Top Players by Dermatology OTC Medications Price (2021-2026)
  4. 3.4 Global Dermatology OTC Medications Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Dermatology OTC Medications Major Company Production Sites & Headquarters
  6. 3.6 Global Dermatology OTC Medications Company, Product Type & Application
  7. 3.7 Global Dermatology OTC Medications Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Dermatology OTC Medications Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Dermatology OTC Medications Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Dermatology OTC Medications Tier 1, Tier 2, and Tier 3
4 Dermatology OTC Medications Regional Status and Outlook
  1. 4.1 Global Dermatology OTC Medications Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Dermatology OTC Medications Historic Market Size by Region
  3. 4.2.1 Global Dermatology OTC Medications Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Dermatology OTC Medications Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Dermatology OTC Medications Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Dermatology OTC Medications Forecasted Market Size by Region
  7. 4.3.1 Global Dermatology OTC Medications Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Dermatology OTC Medications Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Dermatology OTC Medications Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dermatology OTC Medications by Application
  1. 5.1 Dermatology OTC Medications Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.1.3 Other
  5. 5.2 Global Dermatology OTC Medications Market Size by Application
  6. 5.2.1 Global Dermatology OTC Medications Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Dermatology OTC Medications Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Dermatology OTC Medications Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Dermatology OTC Medications Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Dermatology OTC Medications Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Dermatology OTC Medications Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Dermatology OTC Medications Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Dermatology OTC Medications Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bayer
  2. 6.1.1 Bayer Company Information
  3. 6.1.2 Bayer Business Overview
  4. 6.1.3 Bayer Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bayer Dermatology OTC Medications Product Portfolio
  6. 6.1.5 Bayer Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Dermatology OTC Medications Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Teva
  14. 6.3.1 Teva Company Information
  15. 6.3.2 Teva Business Overview
  16. 6.3.3 Teva Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Teva Dermatology OTC Medications Product Portfolio
  18. 6.3.5 Teva Recent Developments
  19. 6.4 Johnson & Johnson
  20. 6.4.1 Johnson & Johnson Company Information
  21. 6.4.2 Johnson & Johnson Business Overview
  22. 6.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Johnson & Johnson Dermatology OTC Medications Product Portfolio
  24. 6.4.5 Johnson & Johnson Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Novartis Dermatology OTC Medications Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Mylan
  32. 6.6.1 Mylan Company Information
  33. 6.6.2 Mylan Business Overview
  34. 6.6.3 Mylan Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mylan Dermatology OTC Medications Product Portfolio
  36. 6.6.5 Mylan Recent Developments
  37. 6.7 Sun Pharmaceutical
  38. 6.7.1 Sun Pharmaceutical Company Information
  39. 6.7.2 Sun Pharmaceutical Business Overview
  40. 6.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sun Pharmaceutical Dermatology OTC Medications Product Portfolio
  42. 6.7.5 Sun Pharmaceutical Recent Developments
  43. 6.8 Aurobindo
  44. 6.8.1 Aurobindo Company Information
  45. 6.8.2 Aurobindo Business Overview
  46. 6.8.3 Aurobindo Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Aurobindo Dermatology OTC Medications Product Portfolio
  48. 6.8.5 Aurobindo Recent Developments
  49. 6.9 Galderma
  50. 6.9.1 Galderma Company Information
  51. 6.9.2 Galderma Business Overview
  52. 6.9.3 Galderma Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Galderma Dermatology OTC Medications Product Portfolio
  54. 6.9.5 Galderma Recent Developments
  55. 6.10 CR SANJIU
  56. 6.10.1 CR SANJIU Company Information
  57. 6.10.2 CR SANJIU Business Overview
  58. 6.10.3 CR SANJIU Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CR SANJIU Dermatology OTC Medications Product Portfolio
  60. 6.10.5 CR SANJIU Recent Developments
  61. 6.11 Dr. Reddy's
  62. 6.11.1 Dr. Reddy's Company Information
  63. 6.11.2 Dr. Reddy's Business Overview
  64. 6.11.3 Dr. Reddy's Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Dr. Reddy's Dermatology OTC Medications Product Portfolio
  66. 6.11.5 Dr. Reddy's Recent Developments
  67. 6.12 Lupin
  68. 6.12.1 Lupin Company Information
  69. 6.12.2 Lupin Business Overview
  70. 6.12.3 Lupin Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Lupin Dermatology OTC Medications Product Portfolio
  72. 6.12.5 Lupin Recent Developments
  73. 6.13 Bausch Health
  74. 6.13.1 Bausch Health Company Information
  75. 6.13.2 Bausch Health Business Overview
  76. 6.13.3 Bausch Health Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bausch Health Dermatology OTC Medications Product Portfolio
  78. 6.13.5 Bausch Health Recent Developments
  79. 6.14 Cipla
  80. 6.14.1 Cipla Company Information
  81. 6.14.2 Cipla Business Overview
  82. 6.14.3 Cipla Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Cipla Dermatology OTC Medications Product Portfolio
  84. 6.14.5 Cipla Recent Developments
  85. 6.15 Qilu Pharmaceutical
  86. 6.15.1 Qilu Pharmaceutical Company Information
  87. 6.15.2 Qilu Pharmaceutical Business Overview
  88. 6.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Qilu Pharmaceutical Dermatology OTC Medications Product Portfolio
  90. 6.15.5 Qilu Pharmaceutical Recent Developments
  91. 6.16 Almirall
  92. 6.16.1 Almirall Company Information
  93. 6.16.2 Almirall Business Overview
  94. 6.16.3 Almirall Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Almirall Dermatology OTC Medications Product Portfolio
  96. 6.16.5 Almirall Recent Developments
  97. 6.17 Lingrui
  98. 6.17.1 Lingrui Company Information
  99. 6.17.2 Lingrui Business Overview
  100. 6.17.3 Lingrui Dermatology OTC Medications Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Lingrui Dermatology OTC Medications Product Portfolio
  102. 6.17.5 Lingrui Recent Developments
7 North America by Country
  1. 7.1 North America Dermatology OTC Medications Sales by Country
  2. 7.1.1 North America Dermatology OTC Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Dermatology OTC Medications Sales by Country (2021-2026)
  4. 7.1.3 North America Dermatology OTC Medications Sales Forecast by Country (2027-2032)
  5. 7.2 North America Dermatology OTC Medications Market Size by Country
  6. 7.2.1 North America Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Dermatology OTC Medications Market Size by Country (2021-2026)
  8. 7.2.3 North America Dermatology OTC Medications Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Dermatology OTC Medications Sales by Country
  2. 8.1.1 Europe Dermatology OTC Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Dermatology OTC Medications Sales by Country (2021-2026)
  4. 8.1.3 Europe Dermatology OTC Medications Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Dermatology OTC Medications Market Size by Country
  6. 8.2.1 Europe Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Dermatology OTC Medications Market Size by Country (2021-2026)
  8. 8.2.3 Europe Dermatology OTC Medications Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Dermatology OTC Medications Sales by Country
  2. 9.1.1 Asia-Pacific Dermatology OTC Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Dermatology OTC Medications Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Dermatology OTC Medications Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Dermatology OTC Medications Market Size by Country
  6. 9.2.1 Asia-Pacific Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Dermatology OTC Medications Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Dermatology OTC Medications Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Dermatology OTC Medications Sales by Country
  2. 10.1.1 South America Dermatology OTC Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Dermatology OTC Medications Sales by Country (2021-2026)
  4. 10.1.3 South America Dermatology OTC Medications Sales Forecast by Country (2027-2032)
  5. 10.2 South America Dermatology OTC Medications Market Size by Country
  6. 10.2.1 South America Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Dermatology OTC Medications Market Size by Country (2021-2026)
  8. 10.2.3 South America Dermatology OTC Medications Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Dermatology OTC Medications Sales by Country
  2. 11.1.1 Middle East and Africa Dermatology OTC Medications Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Dermatology OTC Medications Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Dermatology OTC Medications Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Dermatology OTC Medications Market Size by Country
  6. 11.2.1 Middle East and Africa Dermatology OTC Medications Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Dermatology OTC Medications Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Dermatology OTC Medications Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Dermatology OTC Medications Value Chain Analysis
  2. 12.1.1 Dermatology OTC Medications Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Dermatology OTC Medications Production Mode & Process
  7. 12.2 Dermatology OTC Medications Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Dermatology OTC Medications Distributors
  10. 12.2.3 Dermatology OTC Medications Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst